Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (NY:GSK)

48.65 -0.59 (-1.20%)
Streaming Delayed Price Updated: 1:40 PM EST, Dec 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about GSK plc American Depositary Shares (Each representing two Ordinary Shares)

< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
42 43 Next >
News headline image
Moderna Stock Has Been Beaten Up; Why The CFO Says Its Story Is 'Misunderstood' ↗
Moderna unveiled promising results in flu on Wednesday, adding to its respiratory suite. 
Via Investor's Business Daily
News headline image
FDA Panel Says Popular OTC Cold, Allergy Medicine Might Be Useless - Stocks To Watch ↗
According to FDA panel experts who reviewed the latest research on the long-questioned phenylephrine, a drug ingredient used in several leading decongestants used by millions of Americans looking for... 
Via Benzinga
News headline image
3 Pharmaceutical Stocks That Are Too Cheap to Ignore ↗
Viatris, GSK, and Organon are all trading at less than 7 times earnings. 
Via The Motley Fool
News headline image
GSK and Earvin “Magic” Johnson to Host Community Awareness Events about Older Adult Risk for RSV at YMCA Locations
From GSK plc
Via Business Wire
News headline image
Peering Into GSK's Recent Short Interest ↗
 
Via Benzinga
News headline image
Looking Into GSK's Recent Short Interest ↗
 
Via Benzinga
News headline image
Vivek Ramaswamy's Parallels With Warren Buffett Run Deeper Than Wanting To Make Roivant The 'Berkshire Hathaway Of Drug Development' ↗
Presidential hopeful Vivek Ramaswamy and Warren Buffett may share different political ideologies but they have at least a couple of things in common. 
Via Benzinga
News headline image
7 Stocks Hedge Funds Are Loading Up On ↗
Hedge funds and many other financial institutions are loading up on these names considered to be among top institutional stock picks. 
Via InvestorPlace
News headline image
GSK To Invest $272M In New Vaccine Facility Near Brussels, Slated To Open In 2027 ↗
GSK Plc (NYSE: GSK) has made an investment of over €250 million ($272 million) in a vaccine facility located in Belgium. 
Via Benzinga
News headline image
3 Growth Stocks to Ride the Coming Bull Market in Style ↗
Bull markets always follow bear markets, and these three companies are growth stocks to buy for the next wave higher 
Via InvestorPlace
News headline image
3 Sorry Pharma Stocks to Sell in August Before It’s Too Late ↗
Factors in the marketplace caused these companies to underperform, making them some of the top pharma stocks to sell. 
Via InvestorPlace
News headline image
A Look Into GSK Inc's Price Over Earnings ↗
 
Via Benzinga
News headline image
Is GSK Stock Worth Buying Right Now? ↗
GSK stock could be a bargain. 
Via The Motley Fool
News headline image
A Look Into GSK's Debt ↗
 
Via Benzinga
News headline image
FDA Greenlights Pfizer's RSV Vaccine: Moms Can Now Protect Babies Before Birth ↗
Monday, the FDA approved Pfizer Inc's (NYSE: PFE) Abrysvo (Respiratory Syncytial Virus Vaccine), the company's bivalent RSV prefusion F (RSVpreF) vaccine, to prevent the infection in infants from birth... 
Via Benzinga
News headline image
GSK Announces AREXVY, Its Respiratory Syncytial Virus (RSV) Vaccine, Is Now Available at All Major US Retail Pharmacies
From GSK plc
Via Business Wire
News headline image
Is GSK an Excellent Dividend Stock to Buy for Passive Income Investors? ↗
GSK offers a robust dividend yield, but that's not the only thing to consider. 
Via The Motley Fool
News headline image
3 Pharma Stocks to Sell in August Before They Crash and Burn ↗
Stay far away from these pharma stocks that are suffering from declining sales and weak pipelines of future products. 
Via InvestorPlace
News headline image
GSK, Pfizer Lock Horns Over Patent Fight Related To Respiratory Syncytial Virus Vaccine ↗
GSK Plc (NYSE: GSK) has sued Pfizer Inc (NYSE: PFE) in Delaware court, alleging that Pfizer's respiratory syncytial virus (RSV) vaccine Abrysvo violates GSK's four patent rights in its RSV  
Via Benzinga
News headline image
GSK's Jemperli Plus Chemo Combo Scores FDA Approval As First New Frontline Treatment For Certain Type Of Endometrial Cancer ↗
The FDA approved GSK plc's (NYSE: GSK) Jemperli (dostarlimab) in combination with carboplatin and paclitaxel, followed by Jemperli as a single agent for primary advanced or recurrent endometrial cancer... 
Via Benzinga
News headline image
Jemperli (dostarlimab-gxly) plus chemotherapy approved in the US as the first new frontline treatment option in decades for dMMR/MSI-H primary advanced or recurrent endometrial cancer
From GSK plc
Via Business Wire
News headline image
If You Can Only Buy One Dividend Stock, It Better Be One of These 7 Names ↗
Here are seven of the best dividend stocks to consider immediately. Better, each of these stocks have strong, stable businesses. 
Via InvestorPlace
News headline image
3 Millionaire-Maker Biotech Stocks to Buy Before the Window Closes ↗
Here are three millionaire maker drug stocks from companies whose drugs could make truly staggering profits. 
Via InvestorPlace
News headline image
GSK Says 'Excellent' Q2 Performance Boosted By Vaccine & HIV Drug Sales, Raises 2023 Outlook ↗
GSK plc (NYSE: GSK) reported Q2 FY23 sales of £7.18 billion ($8.97 billion), up 4% Y/Y on t 
Via Benzinga
News headline image
Pharma Giant GSK Beats Second-Quarter Goals On Growth In Vaccines, General Medicines ↗
Pharmaceutical giant GSK beat expectations for the second quarter and raised its forecast for the full year. GSK stock rose on the news. 
Via Investor's Business Daily
News headline image
Tesla's India Move, Adidas Receives Orders For Massive Unsold Yeezy Inventory, Spotify Raises Subscription Prices: Today's Top Stories ↗
Wall Street Journal 
Via Benzinga
News headline image
GSK-Pfizer Backed HIV-Focused Unit ViiV Healthcare's Cabotegravir Injected Drug, Tablets Secure European Backing For Approval ↗
ViiV Healthcare received a positive opinion from the European Medicines Agen 
Via Benzinga
News headline image
The 3 Most Undervalued Pharma Stocks to Buy Now: July 2023 ↗
Trading below a 15 forward price-to-earnings, these undervalued pharma stocks offer opportunities in an overbought market. 
Via InvestorPlace
News headline image
Why Shares of Vir Biotechnology Are Plunging Thursday ↗
The company had disappointing trial news for one of its lead therapies. 
Via The Motley Fool
News headline image
Intercept Pharma Gets Double Upgrade: Analyst Says OCA Combo Therapy Can Extend PBC Business ↗
HC Wainwright has upgraded Intercept Pharmaceuticals Inc (NASDAQ: ICPT) to Buy from Sell, with a price target of  
Via Benzinga
< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
42 43 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.